On Friday, News Corp(NASDAQ:NWSA)’s shares declined -3.75% to $12.82.
News Corp declared ecently that Chief Financial Officer Bedi A. Singh will take part in the Bank of America Merrill Lynch 2015 Media, Communications & Entertainment Conference on Thursday, September 10, 2015, to be held in Los Angeles, CA. The session will start at 12:00 p.m. PDT (3:00 p.m. EDT).
News Corporation, a media and information services company, focuses on creating and distributing content to consumers and businesses worldwide. The company distributes content and data products, such as The Wall Street Journal, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, Barron’s, MarketWatch, Dow Jones Private Markets, and DJX through various media channels, counting newspapers, newswires, Websites, newsletters, magazines, proprietary databases, conferences, and video, in addition to applications for mobile devices, tablets, and electronic readers.
Kraft Heinz Co (NASDAQ:KHC)’s shares dropped -2.20% to $70.57.
he Kraft Heinz Company is expanding the voluntary recall of select code dates and manufacturing codes of individually-wrapped American slices due to the possibility that a thin strip of the individual packaging film may remain adhered to the slice after the wrapper has been removed. If the film sticks to the slice and is not removed, it could potentially cause a choking hazard.
The original July 31, 2015 recall has been expanded. This product list below is inclusive of the formerly recalled 3 LB and 4 LB sizes of Kraft Singles American and White American pasteurized prepared cheese product with a “Best When Used By” date of 29 DEC 15 through 04 JAN 16, followed by the Manufacturing Code S54 or S55.
The Kraft Heinz Company, through its auxiliaries, operates as a food and beverage company in North America and internationally. It primarily offers food and beverage products, counting cheese, meats, refreshment beverages, coffee, packaged dinners, refrigerated meals, snack nuts, dressings, ketchup, condiments and sauces, frozen food, soups, beans and pasta meals, infant nutrition, and other food and grocery products. The company offers its products under the brands, counting Kraft, Heinz, ABC, Capri Sun, Classico, Jell-O, Kool-Aid, Lunchables, Maxwell House, Ore-Ida, Oscar Mayer, Philadelphia, Planters, Plasmon, Quero, Weight Watchers Smart Ones, and Velveeta.
At the end of Friday’s trade, B&G Foods, Inc. (NYSE:BGS)‘s shares surged 6.44% to $36.19.
General Mills, Inc., (GIS) declared recently it has reached a definitive agreement to sell its Green Giant and Le Sueur vegetable businesses to B&G Foods, Inc., (BGS) for about $765 million in cash, subject to an inventory adjustment at closing.
General Mills will continue to operate the Green Giant business in Europe and select other export markets under license from B&G Foods.
The sale reinforces General Mills’ planned preceding to shape its portfolio for growth, focusing its resources on the brands, categories, and geographic markets that have the greatest future growth opportunities.
The Green Giant and Le Sueur businesses comprised of in the projected transaction, comprised of the U.S., Canada, and select other markets, generated annual net sales of about $585 million in fiscal 2015.
General Mills will provide additional details about the impact of the transaction when it reports its fiscal 2016 first-quarter results on September 22, 2015.
B&G Foods, Inc. manufactures, sells, and distributes shelf-stable food and household products in the United States, Canada, and Puerto Rico. Its portfolio of products comprise hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, maple syrup, molasses, salad dressings, Mexican-style sauces, dry soups, taco shells and kits, salsas, pickles, peppers, tomato-based products, puffed corn and rice snacks, nut clusters, Greek yogurt coated granola bars and bites, and other specialty products.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)), ended its Friday’s trading session with -1.41% loss, and closed at $6.28.
Spectrum Pharmaceuticals ( SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, recently declared that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the Rodman & Renshaw 17th Annual Global Investment Conference being held at the St. Regis Hotel in New York City. The Company presentation is on Thursday, September 10, 2015, at 9:35 AM ET.
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, counting FUSILEV for the treatment of patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with follicular non-Hodgkins lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for the treatment of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; and BELEODAQ injection for patients with relapsed or refractory PTCL.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
